Consider Subcutaneous Insulin to Manage DKA
July 2022
You’ll hear renewed debate about the optimal insulin regimen for treating diabetic ketoacidosis (DKA) in adults.
A recent retrospective study suggests that subcutaneous insulin, instead of IV, reduces ICU admissions...with no difference in hypoglycemia.
This adds to other limited data suggesting subcutaneous insulin is safe and effective for mild to moderate DKA.Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote